メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
設備
プロジェクト
研究成果
データセット
受賞
活動
授業
専門知識、名前、または所属機関で検索
和漢診療学講座
富山大学
医学系
概要
フィンガープリント
ネットワーク
プロファイル
(5)
プロジェクト
(8)
研究成果
(440)
データセット
(2)
受賞
(3)
活動
(50)
フィンガープリント
和漢診療学講座が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Kampo Medicine
65%
Keishibukuryogan
56%
Kampo
49%
Chronic Hepatitis C
46%
Protective Effect
28%
Kampo Formula
27%
Japan
27%
Rheumatoid Arthritis
26%
Herbal Medicine
25%
Inhibitory Effect
25%
Traditional Japanese Medicine
23%
Metabolic Syndrome
22%
Mouse Model
20%
Non-alcoholic Fatty Liver Disease (NAFLD)
20%
Nonalcoholic Steatohepatitis
20%
Sustained Virological Response
19%
Hepatitis C
18%
Uncaria Sinensis
18%
Interferon-α (IFN-α)
17%
Neuronal Death
17%
Isolated Rat Aorta
16%
Free Radicals
16%
Ribavirin
15%
Japanese Kampo Medicine
15%
Pegylated Interferon
15%
Hachimijiogan
14%
Vasodilator
14%
Traditional Medicine
14%
Oketsu
14%
Myasthenia Gravis
14%
Red Blood Cells
13%
Lysis
13%
Ribavirin Treatment
13%
Insulin Resistance
13%
Diabetic
13%
Obesity
12%
Chotosan
12%
Kyushu
11%
Endothelium
11%
Acetylcholine Receptor Antibody
11%
Glutamate
11%
Hemorheology
11%
Population-based Study
11%
Monosodium Glutamate
11%
Oral Administration
11%
Rheumatoid Arthritis Patients
10%
Killer Cell Immunoglobulin-like Receptor
10%
Vascular Function
10%
Lymphocyte Transformation Test
10%
Eculizumab
10%
Okinawa
10%
Cerebellar Granule Neurons
10%
Macrophages
10%
Liver Injury
10%
Dose Effect
10%
Hochuekkito
10%
Virus
10%
Lipid Peroxides
9%
AIDS/HIV
9%
Liver
9%
Peripheral Lymphocytes
9%
Cholesterol
9%
Cerebrovascular Disease
9%
Endothelium-dependent Relaxation
9%
Virological Response
9%
Natural Killer Cells
9%
Nicotinic Acetylcholine Receptor (nAChR)
9%
Spontaneously Hypertensive Rats
9%
Influenza A
9%
Autoimmune Autonomic Ganglionopathy
8%
SHRSP
8%
Cholesterol-fed Rabbit
8%
Disease Activity
8%
Paeoniae Radix Alba
8%
Steatohepatitis
8%
Tokishakuyakusan
8%
Scutellariae Radix
8%
Clinical Features
8%
Telaprevir
8%
Triple Therapy
8%
Galectin-3 (Gal-3)
8%
Cinnamaldehyde
8%
Placebo-controlled
8%
Cognitive Function
8%
Crude Drug
8%
IL28B
8%
Glucose Intolerance
8%
Hepatitis C Virus
8%
Blood Pressure
8%
Hepatocellular Carcinoma
7%
Genotype 1
7%
Autoantibodies
7%
Placebo
7%
Autonomic Dysfunction
7%
Interleukin-2
7%
Combination Therapy
7%
High-fat Diet
7%
Endothelial Function
7%
Immunomodulatory Effect
7%
Beneficial Effects
7%
Pharmacology, Toxicology and Pharmaceutical Science
Kampo Medicine (Drug)
100%
Keishi Bukuryo Gan
52%
Chronic Hepatitis C
44%
Nonalcoholic Fatty Liver
27%
Uncaria
24%
Disease
22%
Mouse Model
19%
Metabolic Syndrome X
19%
Liver Injury
18%
Interferon
17%
Ribavirin
17%
Free Radical
16%
Peginterferon
16%
Leporidae
14%
Placebo
13%
Hepatitis C Virus
13%
Glutamic Acid
12%
Antivirus Agent
11%
Messenger RNA
11%
Hachimijiogan
10%
Syndrome
10%
Tumor Necrosis Factor
10%
Radix Paeoniae
10%
Triacylglycerol
10%
Antioxidant
10%
Hyperlipidemia
9%
Liver Cell Carcinoma
9%
Adverse Event
9%
Rheumatoid Arthritis
9%
Inflammatory Arthritis
9%
Myasthenia gravis
9%
Diabetes Mellitus
9%
Insulin Resistance
8%
Cerebrovascular Disease
8%
Vasodilator Agent
8%
Ischemia
8%
Nitric Oxide
8%
Crude Drug
8%
Telaprevir
8%
Eculizumab
8%
Galectin 3
8%
Cinnamaldehyde
8%
Influenza A
8%
Population Study
8%
Multiinfarct Dementia
8%
Atherosclerosis
7%
Kidney Injury
7%
Alzheimer's Disease
7%
Biological Marker
7%
Infection
7%
Combination Therapy
7%
Stroke Prone Spontaneously Hypertensive Rat
7%
Gerbil
7%
Bu Zhong Yi Qi Tang
7%
Clinical Study
7%
Spontaneously Hypertensive Rat
7%
Superoxide
7%
Scutellariae Radix
6%
HIV
6%
Virus RNA
6%
Cytokine
6%
Lipid Peroxide
6%
Medicinal Plant
6%
Toxic Hepatitis
6%
Cholinergic Receptor Antibody
6%
Coughing
6%
Reactive Oxygen Metabolite
6%
Viscum Album Extract
6%
Blood Stasis
5%
Glutamate Sodium
5%
Rhubarb
5%
Neoplasm
5%
Plasma Protein
5%
Orengedoku to
5%
Escherichia Coli Infection
5%
Triterpene
5%
Observational Study
5%
Curcuma
5%
Controlled Clinical Trial
5%
Hypoxia Inducible Factor 1
5%
Insulin Dependent Diabetes Mellitus
5%
Ob/Ob Mouse
5%
Mixed Infection
5%
Diabetic Retinopathy
5%
Guinea Pig
5%
Procyanidin
5%
Nitric Oxide Donor
5%
Fibrinogen
5%
Hydroxyl Radical
5%
Methanol
5%
Creatinine
5%
Inflammation
5%
Randomized Controlled Trial
5%
Medicine and Dentistry
Kampo
78%
Keishi Bukuryo Gan
33%
Chronic Hepatitis C
27%
Nonalcoholic Fatty Liver
26%
Homeopathy
23%
Liver Injury
17%
Disease
14%
Free Radical
10%
Erythrocyte
10%
Lymphocyte Transformation
10%
Interferon
10%
Glutamate Sodium
10%
Hachimijiogan
10%
Traditional Medicine
10%
Ribavirin
9%
Hepatocellular Carcinoma
9%
Peginterferon
9%
Hepatitis C Virus
9%
Steatohepatitis
9%
Polyp
9%
Diagnosis
8%
Metabolic Syndrome
8%
Tongue
8%
In Vitro
8%
Rheumatoid Arthritis
8%
Inflammatory Arthritis
8%
Population Research
8%
Alzheimer's Disease
7%
Hyperlipidemia
7%
Radix Paeoniae
7%
Kidney Injury
7%
Placebo
7%
Diabetes
6%
Urinary System
6%
Medicine
6%
Cholinergic Receptor Antibody
6%
Gene Expression
6%
Adverse Event
6%
Human Immunodeficiency Virus
6%
Clinical Feature
6%
Spontaneously Hypertensive Rat
6%
Toxic Hepatitis
6%
Hepatitis
5%
Combination Therapy
5%
Antiviral Therapy
5%
CD8 Antigen
5%
Diabetes Mellitus
5%
Macrophage
5%
Infection
5%
Arthritis
5%
Messenger RNA
5%
Galectin 3
5%
Triterpene
5%
False Positive Result
5%
Balloon Occlusion
5%
Endoscopic Hemostasis
5%
Adenoma
5%
Insulin Dependent Diabetes Mellitus
5%
Hypoxia Inducible Factor 1
5%
Cognition
5%
Body Mass Index
5%
Ingestion
5%
Drug Therapy
5%
Clinical Trial
5%
Lymphocyte Subpopulation
5%
Blood Pressure
5%